Profile
Full Name
Immix Biopharma, Inc.Ticker Symbol
IMMXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
December 16, 2021Indexes
Not includedWebsite
http://www.immixbio.comEmployees
18Key Details
Price
$1.57(-6.55%)
Market cap
$43.52M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.76(+14.61% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Immix Biopharma doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Feb 10, 25 HC Wainwright & Co.
BuyJan 6, 25 HC Wainwright & Co.
BuyOct 3, 24 HC Wainwright & Co.
BuyAug 19, 24 HC Wainwright & Co.
BuyJul 26, 24 HC Wainwright & Co.
BuyJul 9, 24 HC Wainwright & Co.
BuyJul 1, 24 HC Wainwright & Co.
BuyAug 14, 23 Roth MKM
BuyFeb 22, 23 Roth MKM
BuyInstitutional Ownership
- What is the ticker symbol for Immix Biopharma?
- Does Immix Biopharma pay dividends?
- What sector is Immix Biopharma in?
- What industry is Immix Biopharma in?
- What country is Immix Biopharma based in?
- When did Immix Biopharma go public?
- Is Immix Biopharma in the S&P 500?
- Is Immix Biopharma in the NASDAQ 100?
- Is Immix Biopharma in the Dow Jones?
- When was Immix Biopharma's last earnings report?
- When does Immix Biopharma report earnings?
- Should I buy Immix Biopharma stock now?
What is the ticker symbol for Immix Biopharma?
The ticker symbol for Immix Biopharma is NASDAQ:IMMX
Does Immix Biopharma pay dividends?
No, Immix Biopharma does not pay dividends
What sector is Immix Biopharma in?
Immix Biopharma is in the Healthcare sector
What industry is Immix Biopharma in?
Immix Biopharma is in the Biotechnology industry
What country is Immix Biopharma based in?
Immix Biopharma is headquartered in United States
When did Immix Biopharma go public?
Immix Biopharma's initial public offering (IPO) was on December 16, 2021
Is Immix Biopharma in the S&P 500?
No, Immix Biopharma is not included in the S&P 500 index
Is Immix Biopharma in the NASDAQ 100?
No, Immix Biopharma is not included in the NASDAQ 100 index
Is Immix Biopharma in the Dow Jones?
No, Immix Biopharma is not included in the Dow Jones index
When was Immix Biopharma's last earnings report?
Immix Biopharma's most recent earnings report was on Nov 12, 2024
When does Immix Biopharma report earnings?
The next expected earnings date for Immix Biopharma is May 9, 2025
Should I buy Immix Biopharma stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions